This study aimed to assess autonomic dysfunction in patients with Familial Mediterranean Fever (FMF), and to explore its association with disease characteristics and comorbidities. Thirty FMF patients and 30 healthy controls were enrolled in this cross-sectional study. Disease features and quality of life were recorded using the Familial Mediterranean Fever Quality of Life Scale (FMF-QoL). The Composite Autonomic Symptom Score-31 (COMPASS-31), Hospital Anxiety and Depression Scale (HADS), Fatigue Severity Scale (FSS), Jenkins Sleep Scale (JSS), and Fibromyalgia Rapid Screening Tool (FiRST) were noted. Parasympathetic nervous system was evaluated by R-R interval variability (RRIV) during normal and deep breathing and 30:15 ratio tests with electromyography, while the sympathetic nervous system was assessed by sympathetic skin response (SRR), blood pressure response to standing and sustained handgrip tests. FMF patients had higher total median COMPASS-31 scores than controls (15.09 vs. 5.12, p = 0.001), with significantly higher secretomotor, gastrointestinal, bladder, and pupillomotor subdomain scores (p < 0.05). RRIV during normal breathing was lower in the FMF group compared with controls (17.29 vs. 21.27, p = 0.015). No between-group differences were observed in sympathetic function tests (p > 0.05). In correlation analyses, RRIV during normal breathing correlated negatively with CRP (r = − 0.378, p = 0.04). Sympathetic parameters showed negative correlations with CRP (left plantar SSR latency: r = − 0.398, p = 0.03; blood pressure response to handgrip: r = − 0.405, p = 0.026) and with annual attack frequency (left plantar SSR amplitude: r = − 0.449, p = 0.01). Total COMPASS-31 scores correlated with FMF-QoL (r > 0.5, p < 0.001), HADS-anxiety (r = 0.550, p = 0.002), HADS-depression (r = 0.633, p < 0.001), FSS (r = 0.600, p < 0.001), JSS (r = 0.705, p < 0.001), and FiRST (r = 0.598, p < 0.001). FMF patients showed predominant parasympathetic dysfunction, while sympathetic findings were limited to correlations suggesting possible subclinical involvement. These autonomic alterations may contribute to reduced quality of life and associated symptoms such as fatigue, depression, and sleep disturbance.

Autonomic dysfunction and its associations with clinical parameters in Familial Mediterranean Fever: a cross-sectional study

期刊论文
出版模式：

开放获取
发表日期：

2026年2月4日

查看全文

İmran Kalkan,
Halise Hande Gezer,
Mehmet Tuncay Duruöz

摘要

This study aimed to assess autonomic dysfunction in patients with Familial Mediterranean Fever (FMF), and to explore its association with disease characteristics and comorbidities. Thirty FMF patients and 30 healthy controls were enrolled in this cross-sectional study. Disease features and quality of life were recorded using the Familial Mediterranean Fever Quality of Life Scale (FMF-QoL). The Composite Autonomic Symptom Score-31 (COMPASS-31), Hospital Anxiety and Depression Scale (HADS), Fatigue Severity Scale (FSS), Jenkins Sleep Scale (JSS), and Fibromyalgia Rapid Screening Tool (FiRST) were noted. Parasympathetic nervous system was evaluated by R-R interval variability (RRIV) during normal and deep breathing and 30:15 ratio tests with electromyography, while the sympathetic nervous system was assessed by sympathetic skin response (SRR), blood pressure response to standing and sustained handgrip tests. FMF patients had higher total median COMPASS-31 scores than controls (15.09 vs. 5.12, p = 0.001), with significantly higher secretomotor, gastrointestinal, bladder, and pupillomotor subdomain scores (p < 0.05). RRIV during normal breathing was lower in the FMF group compared with controls (17.29 vs. 21.27, p = 0.015). No between-group differences were observed in sympathetic function tests (p > 0.05). In correlation analyses, RRIV during normal breathing correlated negatively with CRP (r = − 0.378, p = 0.04). Sympathetic parameters showed negative correlations with CRP (left plantar SSR latency: r = − 0.398, p = 0.03; blood pressure response to handgrip: r = − 0.405, p = 0.026) and with annual attack frequency (left plantar SSR amplitude: r = − 0.449, p = 0.01). Total COMPASS-31 scores correlated with FMF-QoL (r > 0.5, p < 0.001), HADS-anxiety (r = 0.550, p = 0.002), HADS-depression (r = 0.633, p < 0.001), FSS (r = 0.600, p < 0.001), JSS (r = 0.705, p < 0.001), and FiRST (r = 0.598, p < 0.001). FMF patients showed predominant parasympathetic dysfunction, while sympathetic findings were limited to correlations suggesting possible subclinical involvement. These autonomic alterations may contribute to reduced quality of life and associated symptoms such as fatigue, depression, and sleep disturbance.